Cargando…
PB1731: INOTUZUMAB OZOGAMICIN IN LYMPHOID B-CELL MALIGNANCY:A SINGLE CENTER ANALYSIS IN THE REAL WORLD
Autores principales: | LV, Mengnan, He, Yi, Yang, Donglin, MA, Qiaoling, Pang, Aiming, Zhai, Weihua, Wei, Jialin, Huang, Yong, Chen, Xin, Zhang, Guixin, Feng, Sizhou, Han, Mingzhe, Zhang, Rongli, Jiang, Erlie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430324/ http://dx.doi.org/10.1097/01.HS9.0000973784.59213.73 |
Ejemplares similares
-
P1273: COMPARISON OF TOTAL BODY IRRADIATION-BASED WITH CHEMOTHERAPY-BASED MYELOABLATIVE CONDITIONING REGIMENS IN PATIENTS WITH B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN FIRST COMPLETE REMISSION
por: Mengnan, LV, et al.
Publicado: (2023) -
Combination treatment of rituximab and donor platelets infusion to reduce donor‐specific anti‐HLA antibodies for stem cells engraftment in haploidentical transplantation
por: Zhang, Rongli, et al.
Publicado: (2020) -
PB1756: INOTUZUMAB OZOGAMICIN IN THERAPY RELAPSE/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (R/R B-ALL): A SINGLE CENTER EXPERIENCE
por: Antipova, A., et al.
Publicado: (2022) -
Inotuzumab ozogamicin for acute lymphoblastic leukaemia
Publicado: (2019) -
The prognostic impact of previously infectious complications on allogeneic hematopoietic stem cell transplantation for patients with severe aplastic anemia: A single-center, retrospective study
por: Zhang, Yuanfeng, et al.
Publicado: (2022)